Skip to main content
Premium Trial:

Request an Annual Quote

A Bit of a Breach

Tech Crunch reporter Zack Whittaker looks at a customer data breach at Veritas Genetics. The Massachusetts company confirmed that a breach had impacted its "customer-facing portal," but did not provide details on the type of information that was stolen.

A representative for the firm downplayed the data theft in the article, suggesting it affected a "handful" of customers and involved a portal that does not house customers' genetic data, test results, or medical information. 

"Although the stolen data did not include personal health information, it's likely to further fuel concerns that health startups, particularly companies dealing with sensitive DNA and genome information, can't protect their users' data," Whittaker writes.

Kristen Brown, who reported the breach in Bloomberg on Wednesday, noted that Veritas has already sequenced thousands of genomes and plans to reach more than 150,000 genome sequences in the coming years.

"As genetic testing has grown in popularity, so too have concerns about privacy," Brown writes. "Whole-genome sequencing is an expensive, niche product, but cheaper genotyping tests have surged in popularity."

Last week, Veritas announced that its international subsidiary, known as Veritas Intercontinental, had reached a deal to provide whole-genome sequencing, exome sequencing, analysis, and interpretation services in Brazil through the Genomika testing lab.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.